Rohan Dharmakumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rohan Dharmakumar has a total of 418 co-authors. Here are the top co-authors by number of shared publications:
Ivan Cokic
Cedars-Sinai Medical Center, Los Angeles, USA
21 shared publicationsRichard Tang
Department of Radiology and Imaging Sciences and Krannert Cardiovascular Research Center, Indiana University School of Medicine, Indianapolis, Indiana, USA
21 shared publicationsAvinash Kali
Cedars-Sinai Medical Center, Los Angeles, USA
19 shared publicationsAndreas Kumar
Division of Cardiology, Health Sciences North and Northern Ontario School of Medicine University , Sudbury, Ontario
17 shared publicationsDebiao Li
Biomedical Imaging Research Institute, Cedars‐Sinai Medical Center Los Angeles California USA
17 shared publicationsHsin-Jung Yang
Biomedical Imaging Research Institute
17 shared publications
Latest Publications
- 31 August 2026
- Published by Oxford University Press (OUP) in European Heart Journal
Intravenous dexrazoxane for haemorrhagic myocardial infarction: the SHIELD-MI study
Background and Aims: Intramyocardial haemorrhage (IMH) after reperfused ST-elevation myocardial infarction is associated with adverse outcomes, yet no therapy specifically targets it. Dexrazoxane (DXZ) may mitigate iron-mediated injury from IMH. Methods: SHIELD-MI was a single-centre, non-randomized, placebo-controlled, sequential-cohort phase IIa study with participants and the cardiac MRI (CMR) core laboratory blinded to treatment. Twenty-five patients received intravenous DXZ 250 mg before primary percutaneous coronary intervention and at 4, 8, and 12 h thereafter. Twenty-five comparators, selected from 78 placebo-treated patients, were matched on total ischaemic time, culprit territory, and pre-percutaneous coronary intervention occlusion status. Primary endpoints were left ventricular ejection fraction (LVEF) and IMH volume on CMR at 48–72 h, evaluating early ventricular function and haemorrhagic myocardial injury after reperfusion. Results: In the matched analytic cohort (n = 50), LVEF was higher in patients receiving DXZ (39.8 ± 7.7% vs 34.7 ± 10.1%; P = .048), permitting formal testing of IMH volume, which was lower with DXZ (2.0 ± 3.4% LV vs 6.3 ± 6.0% LV; P = .004). The prespecified fixed-sequence criterion was therefore met at both steps. Infarct size was lower with DXZ (29.1 ± 13.1% LV vs 43.8 ± 18.6% LV; P = .002). Haemorrhagic MI occurred in 6/25 (24%) vs 16/25 (64%) participants (P = .010). No drug-related serious adverse events were observed. Conclusions: Peri-procedural intravenous DXZ was associated with lower IMH and infarct size and higher LVEF, without safety concerns. These exploratory findings identify IMH as a candidate therapeutic target warranting a randomized trial.
- 31 August 2026
- Published by Oxford University Press (OUP) in European Heart Journal
Intravenous dexrazoxane for haemorrhagic myocardial infarction: the SHIELD-MI study
Background and Aims: Intramyocardial haemorrhage (IMH) after reperfused ST-elevation myocardial infarction is associated with adverse outcomes, yet no therapy specifically targets it. Dexrazoxane (DXZ) may mitigate iron-mediated injury from IMH. Methods: SHIELD-MI was a single-centre, non-randomized, placebo-controlled, sequential-cohort phase IIa study with participants and the cardiac MRI (CMR) core laboratory blinded to treatment. Twenty-five patients received intravenous DXZ 250 mg before primary percutaneous coronary intervention and at 4, 8, and 12 h thereafter. Twenty-five comparators, selected from 78 placebo-treated patients, were matched on total ischaemic time, culprit territory, and pre-percutaneous coronary intervention occlusion status. Primary endpoints were left ventricular ejection fraction (LVEF) and IMH volume on CMR at 48–72 h, evaluating early ventricular function and haemorrhagic myocardial injury after reperfusion. Results: In the matched analytic cohort (n = 50), LVEF was higher in patients receiving DXZ (39.8 ± 7.7% vs 34.7 ± 10.1%; P = .048), permitting formal testing of IMH volume, which was lower with DXZ (2.0 ± 3.4% LV vs 6.3 ± 6.0% LV; P = .004). The prespecified fixed-sequence criterion was therefore met at both steps. Infarct size was lower with DXZ (29.1 ± 13.1% LV vs 43.8 ± 18.6% LV; P = .002). Haemorrhagic MI occurred in 6/25 (24%) vs 16/25 (64%) participants (P = .010). No drug-related serious adverse events were observed. Conclusions: Peri-procedural intravenous DXZ was associated with lower IMH and infarct size and higher LVEF, without safety concerns. These exploratory findings identify IMH as a candidate therapeutic target warranting a randomized trial.
- Top Cited Papers
- 28 August 2026
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (40) , 5911-5958
Fifth Universal Definition of Myocardial Infarction (2026)
- 28 August 2026
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (40) , 5911-5958
Top Cited PapersFifth Universal Definition of Myocardial Infarction (2026)
- 1 July 2026
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 12 (4) , 045001
The importance of spatial resolution in detecting chronic myocardial iron remnants following hemorrhagic myocardial infarction with T2* MRI
Purpose . Intramyocardial hemorrhage following revascularized myocardial infarction is associated with increased mortality and morbidity. T2* cardiac MRI is the noninvasive imaging standard for visualizing the chronic iron deposits from hemorrhagic myocardial infarction (hMI). However, the impact of spatial resolution on detection performance of these iron deposits remains unclear. Methods . We investigated the influence of spatial resolution on the detection of iron deposits following hMI using (i) digital phantom simulations across voxel sizes (0.4–2.0 mm 2 in-plane; 2–8 mm slice thickness) at multiple Signal-to-noise ratio (SNR) levels, (ii) ex-vivo swine hearts ( n = 10) with 8 week hMI. ex-vivo imaging studies employed multi-gradient-echo sequences with various in-plane and through-plane resolutions with minimal SNR constraints ( Unconstrained Acquisitions ) and with in-vivo time constraints ( Constrained Acquisitions ), and (iii) in-vivo T2* imaging at standard spatial resolution (1.6 × 1.6 × 6 mm 3 ). Detection performance was assessed using receiver operating characteristics analysis and its area-under-the-curve (AUC), along with SNR and contrast-to-noise-ratio. Histopathology and mass spectrometry validated iron distribution. Results . Simulations demonstrated that finer voxels minimized partial volume but reduced SNR, while coarser voxels increased SNR but masked focal lesions. Optimal performance (AUC = 0.80) was identified at 1.3–1.6 mm 2 pixel size with 2–4 mm slice thickness under Constrained Acquisitions . Detection accuracy declined sharply for iron depositions that were thin in the transmural direction (μ g g −1 , p = 0.012) and correlated with the transmural width of hMI remnants ( R 2 = 0.83). Conclusion . Spatial resolution critically determines the detectability of chronic iron remnants on T2* maps. While current clinical protocols can identify larger deposits, small (<1 mm) yet proinflammatory lesions may be missed. These results highlight the need for technical improvements to enhance detection.
- 1 July 2026
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 12 (4) , 045001
The importance of spatial resolution in detecting chronic myocardial iron remnants following hemorrhagic myocardial infarction with T2* MRI
Purpose . Intramyocardial hemorrhage following revascularized myocardial infarction is associated with increased mortality and morbidity. T2* cardiac MRI is the noninvasive imaging standard for visualizing the chronic iron deposits from hemorrhagic myocardial infarction (hMI). However, the impact of spatial resolution on detection performance of these iron deposits remains unclear. Methods . We investigated the influence of spatial resolution on the detection of iron deposits following hMI using (i) digital phantom simulations across voxel sizes (0.4–2.0 mm 2 in-plane; 2–8 mm slice thickness) at multiple Signal-to-noise ratio (SNR) levels, (ii) ex-vivo swine hearts ( n = 10) with 8 week hMI. ex-vivo imaging studies employed multi-gradient-echo sequences with various in-plane and through-plane resolutions with minimal SNR constraints ( Unconstrained Acquisitions ) and with in-vivo time constraints ( Constrained Acquisitions ), and (iii) in-vivo T2* imaging at standard spatial resolution (1.6 × 1.6 × 6 mm 3 ). Detection performance was assessed using receiver operating characteristics analysis and its area-under-the-curve (AUC), along with SNR and contrast-to-noise-ratio. Histopathology and mass spectrometry validated iron distribution. Results . Simulations demonstrated that finer voxels minimized partial volume but reduced SNR, while coarser voxels increased SNR but masked focal lesions. Optimal performance (AUC = 0.80) was identified at 1.3–1.6 mm 2 pixel size with 2–4 mm slice thickness under Constrained Acquisitions . Detection accuracy declined sharply for iron depositions that were thin in the transmural direction (μ g g −1 , p = 0.012) and correlated with the transmural width of hMI remnants ( R 2 = 0.83). Conclusion . Spatial resolution critically determines the detectability of chronic iron remnants on T2* maps. While current clinical protocols can identify larger deposits, small (<1 mm) yet proinflammatory lesions may be missed. These results highlight the need for technical improvements to enhance detection.
- Open Access
- 11 June 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (7) , 102864
Predicting Intramyocardial Hemorrhage Before Reperfusion in STEMI Patients With Intrinsically Explainable Artificial Intelligence
- 11 June 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (7) , 102864
Open AccessPredicting Intramyocardial Hemorrhage Before Reperfusion in STEMI Patients With Intrinsically Explainable Artificial Intelligence
- 1 May 2026
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 19 (5) , e019900
Hemorrhagic Myocardial Infarction: Who Is at Risk?
- 1 May 2026
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 19 (5) , e019900
Hemorrhagic Myocardial Infarction: Who Is at Risk?
- Open Access
- 17 April 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (5) , 102740
A New ICD-10 Code for Hemorrhagic Myocardial Infarction
- 17 April 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (5) , 102740
Open AccessA New ICD-10 Code for Hemorrhagic Myocardial Infarction
- Open Access
- 26 March 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (17) , 107612
Hemorrhagic Myocardial Infarction Implicating Left Ventricular Thrombus
- 26 March 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (17) , 107612
Open AccessHemorrhagic Myocardial Infarction Implicating Left Ventricular Thrombus
- 25 March 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 18 (842) , eady6269
Quantifying myocardial oxygen consumption and efficiency with motion-resolved cardiac MRI
Relentless mechanical work of the heart is powered by continuous oxygen consumption. How the heart uses oxygen is a defining feature of its health. Invasive studies have established that impaired oxygen consumption by the myocardium predicts contractile dysfunction and adverse outcomes. Despite its importance, noninvasive quantification of myocardial oxygen use remains limited. Magnetic resonance imaging (MRI) signal is known to be sensitive to blood oxygenation and has the potential to quantify myocardial oxygen consumption noninvasively, without exogenous contrast agents and free of ionizing radiation. However, its clinical translation has been impeded by the need for complex biophysical calibration, vulnerability to imaging artifacts and consistent vital motions, and the requirement of lengthy acquisition times. Here, we introduce a rapid, self-calibrated cardiac MRI framework that overcomes these barriers through high-resolution, motion-resolved coronary sinus oximetry, which can quantify myocardial oxygen extraction of the whole heart within 3 minutes. We optimized the imaging parameters via numerical simulations and validated them against invasive coronary sinus catheterization in a porcine model. We combined the method with clinical MRI sequences and demonstrated the feasibility of quantifying myocardial oxygen consumption and myocardial oxygen efficiency in patients with and without heart failure secondary to myocardial infarction in a single institution. This needle-free approach establishes a practical framework for noninvasive characterization of myocardial oxygen metabolism. It holds the potential to facilitate early disease detection, inform personalized therapeutic strategies, and guide the development of cardiometabolic therapies aimed at addressing the ongoing heart failure epidemic.
- 25 March 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 18 (842) , eady6269
Quantifying myocardial oxygen consumption and efficiency with motion-resolved cardiac MRI
Relentless mechanical work of the heart is powered by continuous oxygen consumption. How the heart uses oxygen is a defining feature of its health. Invasive studies have established that impaired oxygen consumption by the myocardium predicts contractile dysfunction and adverse outcomes. Despite its importance, noninvasive quantification of myocardial oxygen use remains limited. Magnetic resonance imaging (MRI) signal is known to be sensitive to blood oxygenation and has the potential to quantify myocardial oxygen consumption noninvasively, without exogenous contrast agents and free of ionizing radiation. However, its clinical translation has been impeded by the need for complex biophysical calibration, vulnerability to imaging artifacts and consistent vital motions, and the requirement of lengthy acquisition times. Here, we introduce a rapid, self-calibrated cardiac MRI framework that overcomes these barriers through high-resolution, motion-resolved coronary sinus oximetry, which can quantify myocardial oxygen extraction of the whole heart within 3 minutes. We optimized the imaging parameters via numerical simulations and validated them against invasive coronary sinus catheterization in a porcine model. We combined the method with clinical MRI sequences and demonstrated the feasibility of quantifying myocardial oxygen consumption and myocardial oxygen efficiency in patients with and without heart failure secondary to myocardial infarction in a single institution. This needle-free approach establishes a practical framework for noninvasive characterization of myocardial oxygen metabolism. It holds the potential to facilitate early disease detection, inform personalized therapeutic strategies, and guide the development of cardiometabolic therapies aimed at addressing the ongoing heart failure epidemic.
- Open Access
- 3 March 2026
- Published by Oxford University Press (OUP) in Radiology Advances
- Vol. 3 (2)
A 20-minute, free-running, whole-heart cardiac MRI to image myocardial injury following reperfused myocardial infarction: demonstration in a large animal model
Background: Staging irreversible tissue injury in myocardial infarction (MI) enables risk assessment for post-MI major cardiovascular events. While cardiac MRI is the preferred modality for staging the severity of tissue injury, conventional scan protocols require long acquisition times with multiple breath-held and ECG-gated acquisitions, limiting its utilization. Purpose: To develop a free-breathing, whole-heart, non-ECG gated cardiac MRI for staging irreversible tissue injury in MI that can be completed in 50%. The cardiac MRI evidence of tissue injury was confirmed on histopathology in all cases. The agreements between the proposed and conventional methods for LVEF, MI volume, persistent MVO volume and IMH volume were excellent; limits of agreement (LoA) were −2.1%-1.8%, −2.9%-3.3%, −2.4%-4.1%, and −1.5%-1.5%, respectively. MI transmurality and early MVO showed good agreement; LoA were −6.8%-9.7% and −6.6%-8.2%, respectively. Conclusion: The proposed free-breathing, whole-heart, non-ECG gated cardiac MRI approach permits accurate determination of tissue injury in a canine model with >2-fold reduction in scan time. While the method remains to be tested in patients, it has the potential to facilitate efficient use of cardiac MRI for staging the severity of tissue injury in patients with reperfused MI.
- 3 March 2026
- Published by Oxford University Press (OUP) in Radiology Advances
- Vol. 3 (2)
Open AccessA 20-minute, free-running, whole-heart cardiac MRI to image myocardial injury following reperfused myocardial infarction: demonstration in a large animal model
Background: Staging irreversible tissue injury in myocardial infarction (MI) enables risk assessment for post-MI major cardiovascular events. While cardiac MRI is the preferred modality for staging the severity of tissue injury, conventional scan protocols require long acquisition times with multiple breath-held and ECG-gated acquisitions, limiting its utilization. Purpose: To develop a free-breathing, whole-heart, non-ECG gated cardiac MRI for staging irreversible tissue injury in MI that can be completed in 50%. The cardiac MRI evidence of tissue injury was confirmed on histopathology in all cases. The agreements between the proposed and conventional methods for LVEF, MI volume, persistent MVO volume and IMH volume were excellent; limits of agreement (LoA) were −2.1%-1.8%, −2.9%-3.3%, −2.4%-4.1%, and −1.5%-1.5%, respectively. MI transmurality and early MVO showed good agreement; LoA were −6.8%-9.7% and −6.6%-8.2%, respectively. Conclusion: The proposed free-breathing, whole-heart, non-ECG gated cardiac MRI approach permits accurate determination of tissue injury in a canine model with >2-fold reduction in scan time. While the method remains to be tested in patients, it has the potential to facilitate efficient use of cardiac MRI for staging the severity of tissue injury in patients with reperfused MI.